SFERA Archivio dei prodotti della Ricerca dell'Università di Ferrara

CACCIARI, Barbara
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 12.329
AS - Asia 6.101
EU - Europa 4.803
SA - Sud America 1.040
Continente sconosciuto - Info sul continente non disponibili 123
AF - Africa 92
OC - Oceania 6
Totale 24.494
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 12.070
FI - Finlandia 2.064
SG - Singapore 2.061
CN - Cina 1.709
BR - Brasile 803
UA - Ucraina 696
VN - Vietnam 665
DE - Germania 518
HK - Hong Kong 511
TR - Turchia 482
GB - Regno Unito 369
IT - Italia 282
SE - Svezia 256
FR - Francia 212
RU - Federazione Russa 157
BD - Bangladesh 139
IN - India 123
JP - Giappone 119
CA - Canada 108
MX - Messico 108
AR - Argentina 85
PL - Polonia 69
EC - Ecuador 44
ID - Indonesia 44
ZA - Sudafrica 42
IQ - Iraq 41
NL - Olanda 34
PK - Pakistan 33
CO - Colombia 31
ES - Italia 25
BE - Belgio 23
VE - Venezuela 23
SA - Arabia Saudita 21
PY - Paraguay 18
MY - Malesia 17
PH - Filippine 17
UZ - Uzbekistan 16
LT - Lituania 13
MA - Marocco 13
TW - Taiwan 13
AE - Emirati Arabi Uniti 12
CL - Cile 12
IE - Irlanda 12
AT - Austria 11
CR - Costa Rica 11
PE - Perù 11
TN - Tunisia 10
KZ - Kazakistan 8
NP - Nepal 8
AL - Albania 7
CZ - Repubblica Ceca 7
JM - Giamaica 7
JO - Giordania 7
LB - Libano 7
UY - Uruguay 7
AZ - Azerbaigian 6
BO - Bolivia 5
CH - Svizzera 5
EG - Egitto 5
HN - Honduras 5
IR - Iran 5
KE - Kenya 5
KG - Kirghizistan 5
KR - Corea 5
PA - Panama 5
PT - Portogallo 5
RO - Romania 5
TT - Trinidad e Tobago 5
AU - Australia 4
BG - Bulgaria 4
BY - Bielorussia 4
DK - Danimarca 4
ET - Etiopia 4
RS - Serbia 4
SY - Repubblica araba siriana 4
HR - Croazia 3
KW - Kuwait 3
MN - Mongolia 3
NI - Nicaragua 3
PS - Palestinian Territory 3
TH - Thailandia 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AO - Angola 2
BA - Bosnia-Erzegovina 2
BH - Bahrain 2
CI - Costa d'Avorio 2
GT - Guatemala 2
HU - Ungheria 2
IL - Israele 2
LV - Lettonia 2
LY - Libia 2
MD - Moldavia 2
ME - Montenegro 2
NZ - Nuova Zelanda 2
OM - Oman 2
PR - Porto Rico 2
AF - Afghanistan, Repubblica islamica di 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
GA - Gabon 1
Totale 24.357
Salva come PNG Salva come JPEG
Città #
Helsinki 1.915
Singapore 1.283
Ashburn 1.250
Woodbridge 977
Fairfield 914
Dallas 868
Houston 782
San Jose 745
Jacksonville 715
Chandler 593
Hong Kong 499
Santa Clara 489
Ann Arbor 488
Beijing 427
Seattle 367
Wilmington 358
Council Bluffs 295
Cambridge 265
Nanjing 243
Izmir 222
Ho Chi Minh City 213
Princeton 160
Hanoi 153
Los Angeles 148
Lauterbourg 117
Tokyo 114
Boardman 112
New York 91
San Diego 91
Shenyang 77
São Paulo 77
Mexico City 68
Nanchang 67
Munich 62
Dong Ket 61
Hefei 60
Warsaw 58
Milan 53
Orem 52
Shanghai 48
Ferrara 44
Jiaxing 41
Tianjin 41
Brooklyn 39
Buffalo 38
Chicago 38
Phoenix 38
San Mateo 37
London 36
Falkenstein 34
Hebei 34
Kunming 32
Changsha 31
Jinan 31
Zhengzhou 31
Chennai 30
Dearborn 30
San Francisco 30
Rio de Janeiro 29
Frankfurt am Main 28
Da Nang 27
Toronto 27
Falls Church 26
Philadelphia 25
Montreal 24
Amsterdam 22
Brussels 22
Norwalk 22
Denver 21
Moscow 21
Haiphong 20
Manchester 20
Stockholm 20
The Dalles 20
Baghdad 19
Jakarta 19
Johannesburg 19
Ningbo 19
Turku 19
Guangzhou 18
Addison 17
Atlanta 16
Istanbul 16
Biên Hòa 15
Hải Dương 15
Mountain View 15
Rome 15
Bremen 14
Charlotte 14
Taizhou 14
Tashkent 14
Boston 13
Curitiba 13
Quito 13
Verona 13
Dublin 12
Guayaquil 12
Montréal 12
Mumbai 12
Porto Alegre 12
Totale 16.976
Salva come PNG Salva come JPEG
Nome #
1,2,3-triazolo[5,4-e]1,2,4-triazolo[1,5-c]pyrimidine derivatives: A new class of A(2A) adenosine receptor antagonists 3.065
[2,1-c][1,4]benzodiazepine (PBD)-distamycin hybrid inhibits DNA binding to transcription factor Sp1 540
1-methyl-3-nitro-5-methoxycarbonyl pyrazole 302
5,7-Disubstituted-[1,2,4]triazolo[1,5-a][1,3,5]triazines as pharmacological tools to explore the antagonist selectivity profiles toward adenosine receptors 274
[H-3]MRE 3008F20: A novel antagonist radioligand for the pharmacological and biochemical characterization of human A(3) adenosine receptors 264
6-Amino-2-mercapto-3H-pyrimidin-4-one derivatives as new candidates for the antagonism at the P2Y12 receptors 251
Antiproliferative effects of novel synthetic nucleobase analogues on U937 Histiocytic lymphoma cell line 249
5-heteroarylcarbamoylamino-pyrazolo-triazolo pyrimidines as hA3 adenosine receptor antagonists. 241
1H-pyrazolo[2,3-d][1,2,4]triazine-3,7-diones as a new class of human leukocyte elastase inhibitors 230
Schematic overview of oligosaccharides, with survey on their major physiological effects and a focus on milk ones 230
Synthesis, in vitro antiproliferative activity, and DNA-binding properties of hybrid molecules containing pyrrolo[2,1-c][1,4] benzodiazepine and minor-groove-binding oligopyrrole carriers 230
7-substituted 5-amino-2-(2-furyl)pyrazolo[4,3-e]-1,2,4-triazolo[1,5-c]pyrimidines as A(2A) adenosine receptor antagonists: A study on the importance of modifications at the side chain on the activity and solubility 223
7-substituted-5-amino-2-(furyl)-pyrazolo[4,3-e]1,2,4-triazolo[1,5-c]pyrimidines as A2A adenosine receptor antagonists: importance of modifications at the side chain on the activity and solubility. 220
A new synthetic approach to indazole synthesis 216
1H-pyrazolo[4,3-d]pyrimidine-7(6H)-one and 5H-pyrazolo[4,3-d] 1,2,3-triazin-4(3H)-one derivatives. Synthesis and in vitro biological activity at adenosine A1 and A2a receptors 214
8-(2-Furyl)adenine derivatives as A₂A adenosine receptor ligands 213
[3H]-MRE 3008-F20: a novel antagonist radioligand for the pharmacological and biochemical characterization of human A3 adenosine receptors. 211
Design, synthesis, in vitro antiproliferative activity and apoptosis-inducing studies of 1-(3',4',5'-trimethoxyphenyl)-3-(2'-alkoxycarbonylindolyl)-2-propen-1-one derivatives obtained by a molecular hybridisation approach 210
[3H]MRE3008-F20: a novel antagonist radioligand for the pharmacological and biochemical characterization of human A3 adenosine receptors. 203
7-sobstituted-5-amino-2-(furyl)-pyrazolo[4,3-e]1,2,4-triazolo[1,5-c]pyrimidines as A2A adenosine receptor antagonist: importance of modifications at the side chain on the activity and solubility. 201
Pyrazolo[4,3-e][1,2,4]triazolo[1,5-c]pyrimidines and Structurally Simplified Analogs. Chemistry and SAR Profile as Adenosine Receptor Antagonists 200
The influence of the 1-(3-Trifluoromethyl-Benzyl)-1H-Pyrazole-4-yl moiety on the adenosine receptors affinity profile of pyrazolo[4,3-e][1,2,4]Triazolo[1,5-c] pyrimidine derivatives 195
Solid lipid microparticles for the stability enhancement of a dopamine prodrug 191
New potent and selective human adenosine A3 receptor antagonists. 191
Synthesis and properties of substituted CBI analogs of CC-1065 and the duocarmycins incorporating the 7-methoxy-1,2,9,9a-tetrahydrocyclopropa[c]benz[e]indol-4-one (MCBI) alkylation subunit: Magnitude of electronic effects on the functional reactivity 188
New potent and selective human adenosine A3 receptor antagonists 186
Resolution of a CPzI precursor, synthesis and biological evaluation of (+) and (-)-N-Boc-CPzI: A further validation of the relationship between chemical solvolytic stability and cytotoxicity 182
Synthesis and antitumor activity of novel distamycin derivatives 180
Nitrile oxide [3 + 2] cycloaddition: application to the synthesis of 6-substituted 3(2H)-pyridazinones and 6-substituted 4,5-dihydro-4-hydroxy-3(2H)-pyridazinones 179
A novel class of pyrazolo[4,3-e]1,2,4-triazolo[1,5-c]pyrimidines as A3 adenosine receptor antagonists 178
Synthesis and calcium antagonist activity of dialkyl 1,4-dihydro-2,6-dimethyl-4-(nitrogenous heteroaryl)-3,5-pyridine dicarboxylates. 178
Linear and nonlinear 3D-QSAR approaches in tandem with ligand-based homology modeling as a computational strategy to depict the pyrazolo-triazolo- pyrimidine antagonists binding site of the human adenosine A2A receptor 176
A(1) and A(3) adenosine receptor agonists: an overview 175
Oligonucleotides and oligonucleotide conjugates: A new approach for cancer treatment 175
Carbon nanotube substrates boost neuronal electrical signaling 172
Structure Activity Relationship of 4-Amino-2-thiopyrimidine Derivatives as Platelet Aggregation Inhibitors 172
Binding affinity of adenosine receptor agonists and antagonists at human cloned A3 adenosine receptors 171
DNA minor groove alkylating agents structurally related to distamycin A 170
Recent developments in the field of adenosine receptor ligands 170
Synthesis, biological activity, and molecular modeling investigation of new pyrazolo[4,3-e]-1,2,4-triazolo[1,5-c]pyrimidine derivatives as human A(3) adenosine receptor antagonists 169
Synthesis and antitumor activity of a new class of pyrazolo[4,3-e]pyrrolo[1,2-a][1,4]diazepinone analogs of pyrrolo[1,4]benzodiazepines (PBDs) 168
A Novel Conjugated Agent between Dopamine and an A(2A) Adenosine Receptor Antagonist as a Potential Anti-Parkinson Multitarget Approach. 167
A(3) adenosine receptor ligands: History and perspectives 163
A2A-adenosine receptor reserve for coronary vasodilation 163
DNA minor-groove binders: results and design of new antitumor agents 161
Synthesis and Antitumor Activity of a New Class of Pyrazolo[4,3-e]pyrrolo[1,2-a][1,4]diazepinone Analogs of Pyrrolo[1,4][2,1-c]benzodiazepines 161
Pyrazolo-triazolo-pyrimidines as adenosine receptor antagonists: A complete structure-activity profile 160
Chemical Synthesis of [13C]Daidzein 160
Ethyl (R,S)-5-acetyl-4,5-dihydro-3-isoxazoleacetate 160
Synthesis and biological evaluation of new antitubulin agents containing 2-(30,40,50-trimethoxyanilino)-3,6-disubstituted-4,5,6,7-tetrahydrothieno[2,3-c]pyridine Scaffold 160
Synthesis and Biological Evaluation of a New Series of 1,2,4-Triazolo[1,5-a]-1,3,5-triazines as Human A(2A) Adenosine Receptor Antagonists with Improved Water Solubility 158
Structure-activity relationship of novel tallimustine derivatives: Synthesis and antitumor activity 157
Design, synthesis and biological activity of a pyrrolo[2,1-c][1,4]benzodiazepine (PBD)-distamycin hybrid 157
An efficient procedure for the synthesis of 5H-6-substituted-pyrazolo[1,5-d]-1,2,4-triazine-4,7-diones 157
Cosmetic preservation and structure-activity relationships of 4-diazo-pyrazole-5-carboxamides 157
Pyrazolo-triazolo-pyrimidines as adenosine receptor antagonists: Effect of the N-5 bond type on the affinity and selectivity at the four adenosine receptor subtypes 157
New 9-methyl-8-(4-hydroxyphenyl)adenine derivatives as A1 adenosine receptor antagonists 156
Ethyl-(R,S)-5-acetyl-4,5-dihydro-3-isoxazole acetate 155
Effect of A-ring modifications on the DNA-binding behavior and cytotoxicity of pyrrolo[2,1-c] [1,4]benzodiazepines 155
Synthesis and Biological Evaluation of Highly Active 7-Anilino Triazolopyrimidines as Potent Antimicrotubule Agents 155
The Significance of 2-Furyl Ring Substitution with a 2-(para-substituted) Aryl Group in a New Series of Pyrazolo-triazolo-pyrimidines as Potent and Highly Selective hA3 Adenosine Receptors Antagonists: New Insights into Structure-Affinity Relationship and Receptor-Antagonist Recognition 154
Facile and versatile route to the synthesis of fused 2-pyridones: Useful intermediates for polycyclic sytems 153
Synthesis, biological studies and molecular modeling investigation of 1,3-dimethyl-2,4-dioxo-6-methyl-8-(substituted) 1,2,3,4-tetrahydro [1,2,4]-triazolo [3,4-f]-purines as potential adenosine receptor antagonists 153
Unusual Ring-Opening Reaction of 6,7-Dihydrothieno[3,2-d]pyrimidine- 2,4-dione Derivatives Leading to 5-(Alkylthio)-6-vinyluracils 152
Selective binding to human genomic sequences of two synthetic analogues structurally related to U-71184 and adozelesin 151
Fluorosulfonyl- and bis-(beta-chloroethyl)amino-phenylamino functionalized pyrazolo[4,3-e]1,2,4-triazolo[1,5-c]pyrimidine derivatives: Irreversible antagonists at the human A(3) adenosine receptor and molecular modeling studies 150
Synthesis and preliminary biological evaluation of [H-3]-MRE 3008-F20: the first high affinity radioligand antagonist for the human A(3) adenosine receptors 149
CC-1065 and the duocarmycins: recent developments 146
Carbon Nanotubes Carrying Cell-Adhesion Peptides do not Interfere with Neuronal Functionality 146
Pyrazolo[4,3-e]-1,2,4-triazolo[1,5-c]pyrimidine derivatives: Potent and selective A2A adenosine antagonists 145
Demystifying the three dimensional structure of G protein-coupled receptors (GPCRs) with the aid of molecular modeling 145
Synthesis of pyridazine derivatives through the unexpected intermediate 5-amino-4-cyano-2,3-dihydro-furan-2,3-disulfonic acid disodium salt 144
Pyridazine nucleus: a pharmacophoric moiety for bio-active compounds 142
Synthesis and cardiodepressant activity of dialkyl 1,4-dihydro-2,6-dimethyl-4-(pentatomic-heteroaryl)-3,5-pyridinedicarboxylates. 2 141
Pyrazolo [4,3-E]1,2,4-triazolo[1,5-c]pyrimidine derivates a new class of potent and selective human A3 adenosine receptor antagonists. 141
Synthesis of the tritium labeled SCH 58261, a new non-xanthine A(2A) adenosine receptor antagonist 141
Exploring Potency and Selectivity Receptor Antagonist Profiles Using a Multilabel Classification Approach: The Human Adenosine Receptors as a Key Study 139
Binding affinity of adenosine receptor agonists and antagonists at human cloned A3 adenosine receptors 138
Comparative molecular field analysis (CoMFA) of a series of selective adenosine receptor A(2A) antagonists 134
Conjugation of Dopamine and an A2A Adenosine Receptor Antagonist: a possible approach for the treatment of Parkinson’s Disease. 134
Novel N-6-(substituted-phenylcarbamoyl)adenosine-5'-uronamides as potent agonists for A(3) adenosine receptors 130
Synthesis and molecular investigation of new pyrazolo[4,3-e]1,2,4-triazolo[1,5-c]pyrimidine derivates as human A3 adenosine receptor antagonists. 130
Substituted 6-amino-thiouracils as new P2Y(12) receptor antagonists 129
Synthesis and molecular investigation of new pyrazolo[4,3-e]1,2,4,-triazolo[1,5-c]pyrimidine derivates as human A3 adenosine receptor antagonists. 128
Synthesis and pharmacological characterization of a new series of 5,7-disubstituted-[1,2,4]triazolo[1,5-a][1,3,5]triazine derivatives as adenosine receptor antagonists: A preliminary inspection of ligand-receptor recognition process 126
Current developments of A(2a) adenosine receptor antagonists 126
Synthesis and Biological Activity of a New Series of N6-Arylcarbamoyl, 2-(Ar)alkynyl-N6-arylcarbamoyl, and N6-Carboxamido Derivatives of Adenosine-5'-N-ethyluronamide as A1 and A3 Adenosine Receptor Agonists 126
Synthesis, biological and modeling studies of new water soluble hA3 adenosine receptor antagonists. 125
Synthesis and pharmacological characterization of [3H]-MRE3008F20: the first radioligand antagonist for the human A3 adenosine receptors. 125
Rationale design of new human adenosione A3 receptor antagonists through a CoMFA model. 125
Synthesis, antiviral and antiproliferative activity of a new class of 5-(alkyl or arylthio)-6-vinyl uracils 125
2,7-dimethyl-3,8-dinitrodipyrazolo[1,5-a : 1 ',5 '-d]pyrazine-4,9-dione: A new labelling reagent for liquid chromatographic analysis of amino acids 125
Pyrazolo[4,3-e]-1,2,4-triazolo[1,5-c]pyrimidine derivatives as adenosine receptor antagonists. Influence of the N5 substituent on the affinity at the human A(3) and A(2B) adenosine receptor subtypes: A molecular modeling investigation 124
Synthesis, biological properties, and molecular modeling investigation of the first potent, selective, and water-soluble human A(3) adenosine receptor antagonist 124
Heterocyclic analogs of DNA minor groove alkylating agents 123
Binding affinity of adenosine receptor agonists and antagonists at human A3 adenosine receptors 123
A2Aadenosine receptor antagonists as therapeutic candidates: Are they still an interesting challenge? 123
Pyrazolo[4,3-e]-1,2,4-triazolo[1,5-c]-pyrimidine derivatives as highly potent and selective human A(3) adenosine receptor antagonists 122
Synthesis, antibacterial activity and structure-activity relationships of N-substituted 4-diazopyrazole-5-carboxamides. 2 121
Pyrazolo[4,3-e]1,2,4-triazolo[1,5]pyrimidine derivates as irreversible antagonists at the human A3 adenosine receptor 121
Totale 19.971
Salva come PNG Salva come JPEG
Categoria #
all - tutte 102.978
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 581
Totale 103.559
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.184 0 0 78 135 85 51 42 83 38 98 153 421
2022/20231.317 158 63 26 171 220 223 31 118 173 8 73 53
2023/2024810 70 92 34 21 71 60 20 260 12 12 10 148
2024/20252.595 75 134 196 79 329 171 55 201 395 316 379 265
2025/20269.745 660 559 1.299 1.011 901 422 749 334 2.539 893 274 104
2026/2027948 187 451 310 0 0 0 0 0 0 0 0 0
Totale 24.494